New and Noteworthy | Flatiron Health

Showing 9 of 0 results

Ensuring reliability of curated EHR-derived data: The Validation of Accuracy for LLM/ML-Extracted Information and Data (VALID) Framework
JCO Cancer Clinical Informatics
Impact of real-world response to first-line immunotherapy and chemotherapy on subsequent treatment outcomes in patients with advanced or metastatic non-small cell lung cancer
JCO Cancer Clinical Informatics
Persistent gaps in BRCA mutation testing among mCRPC patients: Insights from US cancer practices (2018–2024)
ASCO GU
Beyond BRCA: Real-world outcomes with poly(ADP-ribose) polymerase inhibitors among patients with metastatic castration-resistant prostate cancer and homologous recombination repair mutations
ASCO GU
Real-world (rw) first-line (1L) treatment (tx) patterns and overall survival (rwOS) in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) with frailty or comorbidities
ASCO GU
Opportunities for precision oncology: Real-world patterns and disparities in FGFR3 testing among US patients with locally advanced/metastatic urothelial cancer
ASCO GU
Real-world neoadjuvant therapy utilization and outcomes in patients with muscle-invasive bladder cancer ineligible for cisplatin treatment
ASCO GU
Treatment patterns and survival outcomes among lutetium 177-experienced patients with metastatic castration-resistant prostate cancer
ASCO GU
Validation of composite mortality data in electronic health records-derived data in Germany: Comparison to a German cancer registry
DKK
- Publication summary
- Publications

Publication summary